NCT00937417 2017-04-24S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsSWOG Cancer Research NetworkPhase 1 Withdrawn
NCT01219907 2013-05-17Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast CancerUniversity of WashingtonPhase 1 Withdrawn